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Abstract
Background: The analysis of DNA methylation is a key component in the development of person-
alized treatment approaches. A common way to measure DNA methylation is the calculation of
beta values, which are bounded variables of the form M/(M +U) that are generated by Illumina’s
450k BeadChip array. The statistical analysis of beta values is considered to be challenging, as
traditional methods for the analysis of bounded variables, such as M-value regression and beta
regression, are based on regularity assumptions that are often too strong to adequately describe
the distribution of beta values.
Results: We develop a statistical model for the analysis of beta values that is derived from a bivari-
ate gamma distribution for the signal intensities M and U . By allowing for possible correlations
between M and U , the proposed model explicitly takes into account the data-generating process
underlying the calculation of beta values.
Conclusion: The proposed model can be used to improve the identification of associations between
beta values and covariates such as clinical variables and lifestyle factors in epigenome-wide asso-
ciation studies. It is as easy to apply to a sample of beta values as beta regression and M-value
regression.
1 Background
The analysis of DNA methylation has become of considerable interest in biomedical research, as
epigenetic studies have shown numerous associations between methylation levels and diseases such as
cancer and cardiovascular disease [2, 27, 24, 30, 32]. Today, most research focuses on the cytosine-
guanine dinucleotide (“CpG”) sites of the DNA, which are the locations where methylation is primarily
found in humans [20]. One of the most widely used techniques to measure DNA methylation is the
Illumina Infinium HumanMethylation450 BeadChip array, which covers approximately 450,000 CpG
sites. At each CpG site, methylation is quantified by the beta value b := M/(M + U + a), where
M > 0 and U > 0 denote the methylated and unmethylated signal intensities, respectively, measured
by the Illumina 450k array. The offset a ≥ 0 is usually set equal to 100 and is added to M + U to
stabilize beta values when both M and U are small.
An important goal of methylation analysis is to identify DNA regions where methylation is associ-
ated with disease status, lifestyle factors and other clinical or sociodemographic variables [5, 31, 7, 28].
This is often achieved by fitting site-wise regression models with dependent variable b and a vector of
covariates X that may also include potential confounders. After model fitting, a common strategy is
to carry out downstream hypothesis tests to identify those CpG sites that show significant associations
between methylation status and the variables of interest.
Because, by definition, b is bounded between 0 and 1, Gaussian regression with untransformed
beta values is problematic in the context of DNA methylation analysis. In particular, the variance of b
is usually smaller near the boundaries than near the middle of the interval (0,1), implying that the
homoscedasticity assumption in Gaussian regression is violated [9, 15, 26]. To address this problem,
several modeling strategies have been developed, including Gaussian regression with logit-transformed
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beta values (“M-values”, [9]) and generalized regression models for untransformed bounded responses,
e.g. beta regression [10]. Regarding the analysis of DNA methylation, both strategies are intrinsically
problematic: In case of M-value regression, the assumptions of a Gaussian model are often not met
despite the transformation of the data, and the interpretation of the coefficient estimates is only
possible on the transformed scale but not on the original scale of b [10, 3]. Beta regression, on the
other hand, requires the ratio M/(M + U + a) to follow a beta distribution, implicitly assuming that
the variables M and U are independently gamma distributed [6]. While M and U can indeed be
described by gamma distributed random variables [29, 23], the independence assumption for the two
signal intensities is often not met in practice. For example, Laird [15] reported that the methylated
and unmethylated signal intensities, as produced by the Illumina 450k array, are usually positively
correlated. These issues, along with the results of two recent empirical studies [23, 31], suggest that
both M-value regression and beta regression need to be improved to describe the distribution of b in
a statistically sound way.
To address this problem, we propose a novel analysis technique for beta values that relaxes the
independence assumption between the signal intensities M and U . The idea is to start with a model
for the bivariate distribution of M and U and to derive the probability density function of the ratio
M/(M+U). This function is subsequently used to construct the log-likelihood function of a generalized
regression model that relates beta values to linear functions of the covariates. Because estimation of
the model parameters is based on the maximum likelihood principle, asymptotic confidence intervals
and normally distributed test statistics can be derived by evaluating the inverse of the observed
information matrix. This strategy allows for downstream hypothesis tests on the associations between
a covariate of interest and the methylation status at individual CpG sites. For the rest of this paper,
we will refer to the proposed model as “RCG” (Ratio of Correlated Gammas) model.
2 Methods and Results
In Section 2.1 we introduce basic notation and definitions. Section 2.2 briefly reviews beta regression
and M-value regression and discusses the limitations of the two methods. In Section 2.3 the proposed
RCG model for the analysis of beta values is derived. Section 2.4 provides details on model fitting
and on the construction of downstream hypothesis tests.
2.1 Notation and Definitions
At each CpG site, the Illumina 450k array produces a sample of methylated and unmethylated signal
intensities (Mi, Ui)i=1,...,n, where n is the number of analyzed persons. The corresponding set of
beta values is calculated by bi = Mi/(Mi + Ui + a), i = 1, . . . , n. To facilitate the derivation of
distributional results, we will set a = 0 throughout this section. The predictor variable(s) of interest
and the confounding variables are collected in vectors Xi = (1,Xi1, . . . ,Xip)
⊤, i = 1, . . . , n. For each
CpG site, the aim is to analyze the associations between the variables in X and the methylation
status b.
Following [29] and [23], we assume that the stochastic behavior of the signal intensities M and U
can be described by gamma distributed random variables with densities
fM(m) =
λm
Γ(αm)
(λmm)
αm−1 exp(−λmm) , (1)
fU(u) =
λu
Γ(αu)
(λuu)
αu−1 exp(−λuu) , (2)
where αm, αu and λm, λu are the shape and rate parameters of fM and fU , respectively. From (1)
it follows that the means and variances of M , U are given by αm/λm, αu/λu and αm/λ
2
m, αu/λ
2
u,
respectively [1].
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2.2 Regression Models for the Analysis of Beta Values
Since the ratio b =M/(M+U) is bounded between 0 and 1, it has been argued that a linear regression
model of the form
b = X⊤γ + ǫ , γ ∈ Rp+1 , ǫ ∼ N (0, σ2) , (3)
is not appropriate to model DNA methylation. In particular, the variance of b is usually smaller
near the boundaries than near the middle of the interval (0,1), implying that the homoscedasticity
assumption var(ǫ) = σ2 is violated [9].
In view of this problem, several statistical models for bounded response variables have been de-
veloped (see [26] for an overview). A simple approach is to calculate logit-transformed beta values
(“M-values”, [9]) and to fit a linear regression model of the form
log2
(
b
1− b
)
= X⊤γ + ǫ , ǫ ∼ N (0, σ2) . (4)
Although this strategy has become popular in the analysis of DNA methylation, it has the drawback
that the methylation status (as quantified by the value of b) is not analyzed on its original scale but
on a transformed scale [10]. Furthermore, as shown by Wahl et al. [31], the empirical distribution of
logit-transformed beta values usually deviates from normality.
An alternative approach that operates on the untransformed scale of b is beta regression, which is
characterized by a beta distributed outcome variable with probability density function
ϕ(b) =
Γ(φ)
Γ(µφ)Γ((1− µ)φ) b
µφ−1 (1− b)(1−µ)φ−1 , (5)
where µ and φ denote the mean and precision parameters, respectively, of the probability density
function ϕ. The predictor-response relationship is usually defined by a monotone increasing link
function g(·) and by the model equation g(µ|X) = X⊤γ [10]. A common choice for g is the logit
transformation log(µ/(1 − µ)). Since the variance of a beta distributed random variable is given
by µ(1 − µ)/(1 + φ), beta regression accounts for heteroscedasticity and for small variances near the
boundaries of the interval (0,1). On the other hand, a major shortcoming of (5) in the context of DNA
methylation analysis is that the signal intensities M and U are implicitly assumed to be independent
and to share a common rate parameter. Under these assumptions, the ratio b = M/(M + U) can be
shown to follow a beta distribution ([6], Chapter 9). The independence assumption, however, cannot
be confirmed by empirical findings, which show that the signal intensities obtained from the Illumina
450k array are often positively correlated (see [15]).
2.3 A Statistical Model for the Ratio of Correlated Gamma Distributed Random
Variables
To overcome the problems associated with M-value regression and beta regression, we propose a statis-
tical model (“Ratio of Correlated Gammas (RCG) model”) that is based on the bivariate distribution
of the signal intensities M and U . In contrast to beta regression, we assume that M and U are not
independent but can be described by a bivariate gamma distribution with probability density function
fM,U(m,u) =
(λmλu)
α
(1− ρ) Γ(α)
(
mu
ρλmλu
)α−1
2
exp
(
−λmm
1− ρ
)
× exp
(
− λuu
1− ρ
)
Iα−1
(
2
√
ρλmλumu
1− ρ
)
, (6)
where λm, λu, α > 0, 0 < ρ < 1, and Iα−1 is the modified Bessel function of the first kind of order α−1.
The distribution in (6) is due to Kibble [14] and is often referred to as “Wicksell-Kibble bivariate
gamma distribution” [1]. As stated in various articles and monographs (e.g. [16]), the marginal
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densities fM , fU of M and U , respectively, are given by
fM (m) =
λm
Γ(α)
(λmm)
α−1 exp(−λmm) , (7)
fU (u) =
λu
Γ(α)
(λuu)
α−1 exp(−λuu) . (8)
The equations in (7) and (8) imply that M and U are gamma distributed random variables with a
common shape parameter α and with means and variances given by α/λm, α/λu and α/λ
2
m, α/λ
2
u,
respectively. The restriction to a common shape parameter ensures that all measured signal intensities
refer to probability density functions sharing the same basic form. On the other hand, the unequal
rate parameters λm and λu guarantee sufficient flexibility in modeling the differences in the marginal
densities of M and U (see (11) and (12)). It can further be shown that the Pearson correlation of M
and U is equal to ρ, implying that (6) imposes a correlation structure on the two signal intensities
(see [1]).
In the next step, the distribution of the ratio b =M/(M + U) is derived:
Proposition 1. Let the distribution of (M,U) be defined by the probability density function in (6).
Then the ratio b =M/(M + U) follows a univariate distribution with probability density function
fb(b) =
Γ(2α)
Γ2(α)
(λmλu)
α (1− ρ)α (b(1− b))α−1
× (λmb+ λu(1− b))(
(λmb+ λu(1− b))2 − 4ρλmλub(1− b)
)α+0.5 . (9)
Proof: The proof of Proposition 1, which is related to the work of Nadarajah and Kotz [18], is given
in the appendix.
The result stated in Proposition 1 can be used to derive the log-likelihood function of a sample of
beta values b1, . . . , bn:
Proposition 2. For independent sample values b1, . . . , bn, the log-likelihood function derived from (9)
is given by
n∑
i=1
log(fb(bi;α, ρ, θ)) =
n∑
i=1
[
log(Γ(2α)) − 2 log(Γ(α)) + α log(θ) + α log(1− ρ)
+ log ((θ − 1)bi + 1) + (α− 1) log(bi(1− bi))
− (α+ 0.5) log ( ((θ − 1)bi + 1)2 − 4 ρ θ bi(1− bi))] , (10)
where θ := λm/λu.
Proof: See appendix.
Proposition 2 implies that the log-likelihood function derived from (9) is a function of the mean
ratio θ = λm/λu = E(U)/E(M).
To quantify the associations between the covariates X and the signal intensities M and U , we con-
sider linear predictors X⊤ζm and X
⊤ζu, ζm, ζu ∈ Rp+1, that relate the vector X = (1,X1, . . . ,Xp)⊤
to the marginal means α/λm and α/λu, respectively. A convenient link function that guarantees
the positivity of λm and λu is the logarithmic transformation, resulting in the predictor-response
relationships
log(E(M |X)) = log(α) −X⊤ζm , (11)
log(E(U |X)) = log(α) −X⊤ζu , (12)
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with log(λm) = X
⊤ζm and log(λu) = X
⊤ζu. Note that the term log(α) can be incorporated into the
intercept terms of the coefficient vectors ζm = (ζ0m, ζ1m, . . . , ζpm)
⊤ and ζu = (ζ0u, ζ1u, . . . , ζpu)
⊤. The
model equations in (11) and (12) are therefore in line with traditional univariate gamma regression
approaches that relate the log-transformed mean of the response variable to a linear function of the
predictors.
Defining γ = (γ0, γ1, . . . , γp)
⊤ := ζm − ζu, the mean ratio E(U |X)/E(M |X) can be written
as θ|X = exp(X⊤γ), and the log-likelihood function of a sample (b1,X⊤1 ), . . . , (bn,X⊤n ) becomes
n∑
i=1
log(fb(bi,X i;α, ρ, γ)) =
n∑
i=1
[
log(Γ(2α)) − 2 log(Γ(α)) + αXTi γ
+α log(1− ρ) + log ((exp(XTi γ)− 1) bi + 1)+ (α− 1) log(bi(1− bi))
− (α+ 0.5) log
( (
(exp(XTi γ)− 1) bi + 1
)2 − 4 ρ exp(XTi γ) bi(1− bi))
]
. (13)
Equations (11) to (13) define a statistical model in which the association between the methylation
status b and the covariates X is quantified by the coefficient vector γ. If γk = 0, k ∈ {1, . . . , p},
the predictor-response relationships in (11) and (12) imply that ζkm = ζku and E(M |X) = E(U |X)
(provided that the values of the other covariates remain constant). Hence, if γk = 0, the k-th covari-
ate Xk has the same effect on both M and U , implying that Xk is not associated with the methylation
status at the CpG site under consideration. On the other hand, large values of |γk| result from large
differences in the coefficients ζkm and ζku, implying that DNA methylation varies greatly with the
value of Xk. Assessing the hypotheses “H0 : γk = 0 vs. H1 : γk 6= 0” is therefore equivalent to a
statistical test on the association between b and Xk.
2.4 Estimation and Hypothesis Tests
To obtain a consistent estimator of the coefficient vector γ, the log-likelihood function in (13) needs
to be maximized over both γ and the hyperparameters α and ρ. To this purpose, we propose the
application of a gradient boosting algorithm with linear base-learning functions, as described in [4].
For given data (bi,X
⊤
i )i=1,...,n, gradient boosting is a generic optimizer that minimizes a risk function
R(f, (bi,X⊤i )i=1,...,n) over an unknown prediction function f(X), with the only requirement being the
existence of the derivative ∂R/∂f [13]. Because the base-learning functions are chosen to be linear
in X, the space of the prediction function f is restricted to the subspace defined by f(X) = X⊤γ,
implying that estimation of f reduces to the estimation of the coefficient vector γ (see [11] for a detailed
description of the algorithm). Furthermore, gradient boosting allows for the additional estimation of
the hyperparameters α and ρ [25]. Maximum likelihood (ML) estimates of γ, α and ρ can therefore
be obtained by setting R equal to the negative of the log-likelihood in (13) and by running gradient
boosting until convergence.
By standard maximum likelihood arguments, the hypotheses “H0 : γk = 0 vs. H1 : γk 6= 0”
can be investigated by plugging the ML estimates γˆ, αˆ and ρˆ in the observed information matrix
J(α, ρ, γ) = −∑ni=1 ∂2 log(fb(bi,X i;α, ρ, γ))/∂2γ and by calculating the test statistic
Zk = γˆk
/√
J−1kk (αˆ, ρˆ, γˆ) , k ∈ {1, . . . , p} , (14)
where J−1kk denotes the k-th diagonal element of J
−1. Under the null hypothesis, Zk is asymptotically
standard normally distributed as n→∞. Details on the calculation of J are given in the appendix.
3 Discussion
The development of statistical models to analyze DNA methylation is the subject of intense and
ongoing research [19, 33, 7, 8]. In this paper, we proposed a likelihood-based approach to analyze and
infer the associations between covariates and methylation levels in Illumina 450k data. In contrast
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to beta regression, the proposed RCG model accounts for possible correlations between methylated
and unmethylated signal intensities, thereby increasing the flexibility of the model in describing the
distribution of methylation levels at individual CpG sites.
The use of a gradient boosting algorithm to optimize the parameters of the RCG model lays the
ground for a variety of additional modeling options. For example, it is straightforward to account
for nonlinear covariate effects and to extend the linear predictor in (13) by a set of spline functions.
Furthermore, it is possible to embed the RCG model in the GAMLSS framework [22] and to increase
its flexibility by relating the parameters α and ρ to separate linear or additive predictors. For details,
see [17] and [12].
References
[1] N. Balakrishnan and C.-D. Lai. Continuous Bivariate Distributions. Springer, New York, 2
edition, 2009.
[2] A. Bird. DNA methylation patterns and epigenetic memory. Genes & Development, 16:6–21,
2002.
[3] C. Bock. Analysing and interpreting DNA methylation data. Nature Reviews Genetics, 13:
705–719, 2012.
[4] P. Bu¨hlmann and T. Hothorn. Boosting algorithms: Regularization, prediction and model fitting.
Statistical Science, 22:477–522, 2007.
[5] S. Dedeurwaerder, M. Defrance, M. Bizet, and others. A comprehensive overview of Infinium
HumanMethylation450 data processing. Briefings in Bioinformatics, 15:929–941, 2014.
[6] L. Devroye. Non-Uniform random variate generation. Springer, New York, 1986.
[7] Egor Dolzhenko and Andrew D. Smith. Using beta-binomial regression for high-precision differ-
ential methylation analysis in multifactor whole-genome bisulfite sequencing experiments. BMC
Bioinformatics, 15:215, 2014.
[8] Matthias Do¨ring, Gilles Gasparoni, Jasmin Gries, Karl Nordstro¨m, Pavlo Lutsik, Jo¨rn Walter,
and Nico Pfeifer. Identification and analysis of methylation call differences between bisulfite mi-
croarray and bisulfite sequencing data with statistical learning techniques. BMC Bioinformatics,
16(Suppl 3):A7, 2015.
[9] P. Du, X. Zhang, C.-C. Huang, and others. Comparison of Beta-value and M-value methods for
quantifying methylation levels by microarray analysis. BMC Bioinformatics, 11:587, 2010.
[10] S. L. P. Ferrari and F. Cribari-Neto. Beta regression for modelling rates and proportions. Journal
of Applied Statistics, 31:799–815, 2004.
[11] B. Hofner, A. Mayr, N. Robinzonov, and M. Schmid. Model-based boosting in R: A hands-on
tutorial using the R package mboost. Computational Statistics, 29:3–35, 2014.
[12] B. Hofner, A. Mayr, and M. Schmid. gamboostLSS: An R package for model building and variable
selection in the GAMLSS framework. Journal of Statistical Software, 2016. To appear.
[13] T. Hothorn. Boosting – an unusual yet attractive optimiser. Methods of Information in Medicine,
53:417–418, 2014.
[14] W. F. Kibble. A two-variate gamma type distribution. Sankhya, 5:137–150, 1941.
[15] P. W. Laird. Principles and challenges of genome-wide DNA methylation analysis. Nature Reviews
Genetics, 11:191–203, 2011.
[16] K. V. Mardia. Families of Bivariate Distributions. Griffin, London, 1970.
6
[17] A. Mayr, N. Fenske, [...], and M. Schmid. Generalized additive models for location, scale and
shape for high dimensional data. Journal of the Royal Statistical Society, Series C, 61:403–427,
2012.
[18] S. Nadarajah and S. Kotz. Jensen’s bivariate gamma distribution: Ratios of components. Journal
of Statistical Computation and Simulation, 77:349–358, 2007.
[19] Y. Park, M. E. Figueroa, L. S. Rozek, and M. A. Sartor. MethylSig: A whole genome DNA
methylation analysis pipeline. Bioinformatics, 30:2414–2422, 2014.
[20] A. Portela and M. Esteller. Epigenetic modifications and human disease. Nature Biotechnology,
28:1057–1068, 2010.
[21] A. P. Prudnikov, Y. A. Brychkov, and O. I. Marichev. Integrals and Series. Gordon and Breach
Science Publishers, Amsterdam, 1986.
[22] R. Rigby and D. M. Stasinopoulos. Generalized additive models for location, scale and shape.
Journal of the Royal Statistical Society, Series C, 54:507–554, 2005.
[23] M. Saadati and A. Benner. Statistical challenges of high-dimensional methylation data. Statistics
in Medicine, 33:5347–5357, 2014.
[24] F. H. Sarkar. Epigenetics and Cancer. Springer, Dordrecht, 2013.
[25] M. Schmid, S. Potapov, A. Pfahlberg, and T. Hothorn. Estimation and regularization techniques
for regression models with multidimensional prediction functions. Statistics and Computing, 20:
139–150, 2010.
[26] M. Schmid, F. Wickler, K. O. Maloney, and others. Boosted beta regression. PLoS ONE,
8(4):e61623, 2013.
[27] D. S. Shames, J. D. Minna, and A. F. Gazdar. DNA methylation in health, disease, and cancer.
Current Molecular Medicine, 7:85–102, 2007.
[28] P. Singmann, D. Shem-Tov, S. Wahl, and others. Characterization of whole-genome autosomal
differences of DNA methylation between men and women. Epigenetics & Chromatin, 8:43, 2015.
[29] T. J. Triche, D. J. Weisenberger, D. Van Den Berg, and others. Low-level processing of Illumina
Infinium DNA Methylation BeadArrays. Nucleic Acids Research, 41(7):e90:191–203, 2013.
[30] K. Varley, J. Gertz, K. Bowling, and others. Dynamic DNA methylation across diverse human
cell lines and tissues. Genome Research, 23:555–567, 2013.
[31] S. Wahl, N. Fenske, [...], and M. Schmid. On the potential of models for location and scale for
genome-wide DNA methylation data. BMC Bioinformatics, 15:232, 2014.
[32] N. Zhang, H.-J. Wu, W. Zhang, and others. Predicting tumor purity from methylation microarray
data. Bioinformatics, 31:3401–3405, 2015.
[33] Hao Zheng, Hongwei Wu, Jinping Li, and Shi-Wen Jiang. CpGIMethPred: Computational model
for predicting methylation status of CpG islands in human genome. BMC Medical Genomics,
66(Suppl 1):S13, 2013.
7
Appendix
Proof of Proposition 1
We start with a lemma on the properties of the modified Bessel function of the first kind of order
ν := α− 1.
Lemma 1: For α˜+ ν > 0 and p > c it holds that∫
∞
0
xα˜−1 exp(−px) Iν(cx) dx = p−(α˜+ν)
( c
2
)ν Γ(ν + α˜)
Γ(ν + 1)
2F1
(
ν + α˜
2
,
ν + α˜+ 1
2
, ν + 1,
c2
p2
)
,
where 2F1(·) is the Gauss hypergeometric function (see [18], p. 350). For a formal proof of Lemma 1,
see [21].
The proof of Proposition 1 is obtained by deriving the joint density function fR,b of the random
variables R :=M +U and b =M/(M +U) =M/R. Transforming (M,U) = (Rb,R(1− b)) into (R, b)
yields the Jacobian matrix
J˜ =
(
∂Rb
∂R
∂Rb
∂b
∂R(1−b)
∂R
∂R(1−b)
∂b
)
=
(
b R
(1− b) −R
)
(15)
with |det(J˜)| = R. It follows that, under the assumptions of Proposition 1,
fR,b(r, b) =
(λmλu)
α+1
2
(1− ρ) ρα−12 Γ(α)
rα (b (1− b))α−12 exp
(
−λmrb+ λur(1− b)
1− ρ
)
× Iα−1
(
2
√
ρλmλu r2 b (1 − b)
1− ρ
)
. (16)
Defining
Z(b) :=
∫
rα exp
(
−λmrb+ λur(1− b)
1− ρ
)
Iα−1
(
2
√
ρλmλu r2 b (1− b)
1− ρ
)
dr , (17)
the marginal density function fb(b) is derived by integrating fR,b over R:
fb(b) =
∫
fR,b(r, b) dr =
(λmλu)
α+1
2
(1− ρ) ρα−12 Γ(α)
(b (1 − b))α−12 Z(b) . (18)
Setting
α˜ = α+ 1 , ν = α− 1 , p = λmb+ λu(1− b)
1− ρ , c =
2
√
ρλmλu b (1− b)
1− ρ (19)
and making use of the fact that
2F1 (α, δ, α, x) = (1− x)−δ , (20)
one obtains by application of Lemma 1 that
Z(b) =
Γ(2α)
Γ(α)
(1− ρ)α+1
(√
ρλmλu b (1− b)
)α−1
(λmb+ λu(1− b))2α
(
1− 4ρλmλu b (1− b)
(λmb+ λu(1− b))2
)− 2α+1
2
. (21)
Combining (18) and (21) yields the probability density function stated in Proposition 1.
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Proof of Proposition 2
Defining θ := λm/λu, the log-likelihood function derived from of Equation (9) of the manuscript
becomes
n∑
i=1
log(fb(bi;α, ρ, θ)) =
n∑
i=1
[
log(Γ(2α)) − 2 log(Γ(α)) + α log(λmλu) + α log(1− ρ)
+ (α− 1) log(bi(1− bi)) + log(λmbi + λu(1− bi))
− (α+ 0.5) log ((λmbi + λu(1− bi))2 − 4 ρλmλu bi(1− bi)) ]
=
n∑
i=1
[
log(Γ(2α)) − 2 log(Γ(α)) + α log(θλ2u) + α log(1− ρ)
+ (α− 1) log(bi(1− bi)) + log (λu ((θ − 1) bi + 1))
− (α+ 0.5) log ((λu((θ − 1) bi + 1))2 − 4 ρ θλ2u bi(1− bi)) ]
=
n∑
i=1
[
log(Γ(2α)) − 2 log(Γ(α)) + α log(θ) + α log(1− ρ)
+ (α− 1) log(bi(1− bi)) + log ((θ − 1) bi + 1)
− (α+ 0.5) log (((θ − 1) bi + 1)2 − 4 ρ θ bi(1− bi)) ] . (22)
Derivation of the Observed Information Matrix
Defining D1 := (exp(X
T
i γ)− 1) bi + 1 and D2 := D21 − 4 ρ exp(XTi γ) bi (1− bi), the first derivative of
Equation (13) of the manuscript w.r.t. γ is given by
∂
∂γ
n∑
i=1
log(fb(bi,Xi;α, ρ, γ))
=
n∑
i=1
[
αXTi +
X
T
i bi exp(X
T
i γ)
D1
− (α+ 0.5) 2 (D1 − 2 ρ (1− bi))X
T
i bi exp(X
T
i γ)
D2
]
. (23)
It follows that the observed information matrix is given by
J(α, ρ, γ) = − ∂
2
∂2γ
n∑
i=1
log(fb(bi,X i;α, ρ, γ)) (24)
=
n∑
i=1
[ (D1 − bi exp(XTi γ)) bi exp(XTi γ)X iXTi
D21
− (α+ 0.5) 2 bi exp(X
T
i γ)
(
D1 + bi exp(X
T
i γ)− 2 ρ (1 − bi)
)
XiX
T
i
D2
+(α+ 0.5)
4 b2i exp(2X
⊤
i γ) (D1 − 2ρ(1 − bi))2 XiXTi
D22
]
. (25)
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